October 2nd 2024
Researchers behind the review suggested that future research should prioritize large-scale trials to confirm abrocitinib's long-term safety and efficacy in various skin disorders.
September 30th 2024
Dermatology Times is looking back on the top stories in dermatology from the month of September.
Dermatology Times is recapping our top expert interviews from the month of September.
September 25th 2024
In recent years, there has been a noticeable rise in diagnoses of sexually transmitted infections, often which present with skin findings.
September 24th 2024
VYNE recently announced positive results for its novel oral small molecule BD2-selective BET inhibitor in a single-ascending dose clinical trial.
Top Insights from 5 Influential Leaders at Maui Derm NP+PA Fall
Learn more about the latest in dermatology from Sheila Fallon Friedlander, MD; Melodie Young, MSN, ANP-c; Raj Chovatiya, MD, PhD, MSCI; Julie Harper, MD; and Matthew Zirwas, MD.
Skin Signs of Hereditary Angioedema
Review cutaneous signs and symptoms of HAE that may enhance early diagnosis and treatment.
Henry Lim, MD, Shares Insights into ILDS’ DermImpact Grant Program, Support of Underserved Communities
Lim discusses support for underserved communities, including dermatology training for Pacific Island Nations.
Q&A: AbbVie Immunology Scholarships Provide Support for Students With Chronic Immune-Mediated Diseases
Elyse Love, MD, discusses the role of the program in supporting students with skin conditions the financial support and empowerment necessary for academic success.
Day 4 Recap: Maui Derm NP+PA Fall 2024
Catch up on coverage from the fourth day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee.
Day 3 Recap: Maui Derm NP+PA Fall 2024
Catch up on coverage from the third day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee.
Day 2 Recap: Maui Derm NP+PA Fall 2024
Catch up on coverage from the second day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee.
Jason Hawkes, MD: Urticaria Characteristics, Patient Concerns, and Therapies
During his session at Maui Derm NP+PA Fall, Hawkes emphasized the need for careful patient communication and shared his excitement for remibrutinib.
Day 1 Recap: Maui Derm NP+PA Fall 2024
Catch up on coverage from the first day of the Maui Derm NP+PA Fall 2024 conference in Nashville, Tennessee.
Finger-to-Palm Distance Among Potential Indicators of Skin Thickening, Early-Onset Systemic Sclerosis
Researchers reported several factors and indicators that may predict early-stage systemic sclerosis among patients in Japan.
BD2-Selective BET Inhibitor VYN202 Demonstrates Positive Safety and Tolerability in Phase 1a Trial
The subsequent MAD portion of the study has commenced dosing. Results are anticipated in Q4.
Self-Stigma's Role in Chronic Skin Conditions
A recent reviewed showed that self-stigma in patients with skin disease is influenced by body image issues and social support.
Sanofi Reports High Efficacy in Dupilumab for BP
New study results show promise in dupilumab for bullous pemphigoid, with 59% of patients avoiding disease relapse.
Phase 3 LIBERTY-CUPID Study C Trial for Dupilumab Meets Primary, Secondary Endpoints for Chronic Spontaneous Urticaria
These positive data will support US regulatory submission by end of 2024.
Nearly half of FDA-authorized AI tools may be ineffective
Researchers stated the lack of reported clinical validation data raises concerns about their effectiveness and safety.
Preclinical Medical Students Perform Similarly in Evaluating, Diagnosing Dermatological Diseases in Varying Skin Types
Researchers reported that second-year students were more likely to identify dermatological conditions, particularly in White patients.
Tackle Sports Dermatoses
It is important that dermatology providers can easily recognize and treat communicable sports dermatoses, writes Shanna Miranti, MMS, PA-C.
Publishing Excellence Runs More Than Skin Deep
Exploring the Perception of Digital Health Tools in Dermatology
A recent study investigated the acceptability, barriers, and facilitators associated with digital health tools.
Advanced Laser Eases Acne Scars, Melasma, and Wrinkles
New research shows the 675-nm laser enhances skin texture and rejuvenation, making it a valuable tool for various dermatological conditions.
Denileukin Diftitox-cxdl Gains NCCN Category 2A Recommendation for Cutaneous T-cell Lymphoma Treatment
Citius' recently-approved Lymphir has been added to the National Comprehensive Cancer Network's Clinical Practice Guidelines in Oncology.
Phase 2 Trial Begins for EVO756 in Chronic Inducible Urticaria
The phase 2 trial for EVO756, targeting mast cell-related CIndU, is now underway at 15 US study sites.
Dermatology Times August 2024 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of August.
Interview Intersection: Expert Interviews From August 2024
Dermatology Times is recapping our top expert interviews from the month of August.
Hyaluronic Acid Compound Demonstrates Effective Improvement of Keratosis Pilaris
Researchers observed significant improvements in roughness and redness in patients treated with the non-cross-linked compound.
The Role of AI in Enhancing Cosmetic Dermatology Practices
A recent review highlighted how AI can be used to enhance diagnostic accuracy, consultations, treatment planning, and patient education.
Facial Botox Injections May Elevate Mood, Study Finds
The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.
Case of Juvenile Bullous Pemphigoid with Negative Serum BP180 ELISA Test Reveals Need for Additional Testing
Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.
Daily Collagen Intake Delays Visible Signs of Skin and Nail Aging
A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.
New Toolkit Aims to Boost Diversity in Skin Research
Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.